Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus [NA]
A completed clinical trial evaluated the vasodilatory and metabolic effects of glucagon-like peptide-1 in peripheral circulation in people w…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Acute Exercise and Pancreatic Endocrine Function [NA]
A completed clinical trial investigating the effects of acute exercise on pancreatic endocrine function in people with Type 2 Diabetes.
-
FDA approval · 2014-01-30FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approves a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP, resulting in an update to the product la…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure [Phase 4]
Phase 4 trial comparing insulin glargine to liraglutide after failure of oral agents in Type 2 diabetes mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 dose-ranging study of AVE0010, a GLP-1 receptor agonist, in metformin-treated adults with Type 2 Diabetes Mellitus has completed. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-01-27Clinical Trial Update: Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis [Phase 3]
A Phase 3 clinical trial of fasiglifam in type 2 diabetes patients with chronic kidney disease on hemodialysis has been withdrawn.
-
FDA approval · 2014-01-24FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2014-01-24FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly. This action approves a supplemental submis…
-
FDA approval · 2014-01-23FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for glyburide submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Mechanism of Insulin-Resistant in Lean Non-Diabetics [Phase 1]
A Phase 1 clinical trial conducted by the University of California, San Francisco investigated mechanisms of insulin resistance and insulin …
-
FDA approval · 2014-01-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-01-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc., indicating a…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Welchol as Monotherapy for Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial results evaluating Welchol (colesevelam) as monotherapy for type 2 diabetes mellitus were completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards [Phase 3]
Phase 3 clinical trial evaluating the GlucoTab System for glycemic management in hospitalized patients with Type 2 diabetes mellitus has com…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142) [Phase 1]
A Phase 1 study evaluating and comparing the pharmacokinetic and pharmacodynamic profiles of sitagliptin, saxagliptin, and vildagliptin in p…
-
FDA approval · 2014-01-22FDA Approved: REPAGLINIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s original-application generic repaglinide for use in adults with type 2 diabetes mellitus.
-
FDA approval · 2014-01-22FDA Approved: REPAGLINIDE — Original Application (Chartwell RX, LLC)
FDA approved the original application for repaglinide (generic) by Chartwell RX, LLC, making a generic version of this meglitinide-type oral…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Diabetes and Periodontal Therapy Trial [Phase 3]
A Phase 3 clinical trial evaluating periodontal therapy in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes [Phase 2]
Phase 2 trial update for GWMD1092 (GWP42003/GWP42004) in type 2 diabetes and dyslipidemia; completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: African American Children, Glycemic Control, and Type 2 Diabetes [NA]
A completed clinical trial update focusing on glycemic control in African American children with Type 2 Diabetes and Vitamin D Deficiency.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China [Phase 4]
This update reports the completion of a Phase 4 trial comparing metformin and repaglinide monotherapy for new-onset Type 2 diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects [Phase 2]
Phase 2 clinical trial update for a dietary intervention in Type 2 diabetes mellitus; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
An observational study, sponsored by AstraZeneca, assesses real-world use of exenatide with basal insulin in patients with type 2 diabetes; …
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: R230C and C230C Variants of ABCA1 and Glyburide Response [Phase 4]
Phase 4 clinical trial evaluating the impact of ABCA1 R230C and C230C genetic variants on glyburide response in individuals with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: Electronically Connected Health Coaching in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update evaluating electronically connected health coaching for Type 2 diabetes. The snippet provides no results or …